loading
前日終値:
$6.07
開ける:
$6.09
24時間の取引高:
1.24M
Relative Volume:
0.32
時価総額:
$1.89B
収益:
$493.67M
当期純損益:
$-104.69M
株価収益率:
-18.06
EPS:
-0.34
ネットキャッシュフロー:
$-31.51M
1週間 パフォーマンス:
-1.31%
1か月 パフォーマンス:
-7.97%
6か月 パフォーマンス:
-38.37%
1年 パフォーマンス:
-37.36%
1日の値動き範囲:
Value
$6.06
$6.20
1週間の範囲:
Value
$6.03
$6.38
52週間の値動き範囲:
Value
$5.81
$12.65

Amicus Therapeutics Inc Stock (FOLD) Company Profile

Name
名前
Amicus Therapeutics Inc
Name
セクター
Healthcare (1175)
Name
電話
(609) 662-2000
Name
住所
47 HULFISH STREET, PRINCETON, NJ
Name
職員
499
Name
Twitter
@amicusrx1
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
FOLD's Discussions on Twitter

FOLD を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
FOLD
Amicus Therapeutics Inc
6.135 1.92B 493.67M -104.69M -31.51M -0.34
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.10 25.76B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
446.21 114.53B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.39 40.54M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
83.41 6.44B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
502.07 65.13B 14.09B 4.50B 2.96B 39.28

Amicus Therapeutics Inc Stock (FOLD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-13 ダウングレード Morgan Stanley Overweight → Equal-Weight
2024-09-06 開始されました Jefferies Buy
2024-05-30 開始されました Wells Fargo Overweight
2024-05-14 アップグレード Guggenheim Neutral → Buy
2023-12-19 アップグレード Morgan Stanley Equal-Weight → Overweight
2022-09-09 開始されました Morgan Stanley Equal-Weight
2022-04-13 再開されました Goldman Neutral
2022-01-14 アップグレード SVB Leerink Mkt Perform → Outperform
2021-11-15 アップグレード Stifel Hold → Buy
2021-09-30 アップグレード JP Morgan Neutral → Overweight
2021-07-19 再開されました BTIG Research Buy
2021-05-27 開始されました Needham Hold
2021-05-21 開始されました UBS Buy
2021-04-14 アップグレード Cantor Fitzgerald Neutral → Overweight
2021-03-02 開始されました Stifel Hold
2021-02-12 ダウングレード Cantor Fitzgerald Overweight → Neutral
2021-02-12 ダウングレード JP Morgan Overweight → Neutral
2020-12-28 再開されました Cantor Fitzgerald Overweight
2020-12-10 ダウングレード Citigroup Buy → Neutral
2020-11-11 開始されました Berenberg Hold
2020-06-17 開始されました BTIG Research Buy
2020-02-04 再開されました Cantor Fitzgerald Overweight
2019-11-12 繰り返されました H.C. Wainwright Buy
2019-06-17 開始されました H.C. Wainwright Buy
2019-06-05 繰り返されました Cantor Fitzgerald Overweight
2019-04-05 開始されました Janney Buy
2019-01-30 開始されました Cantor Fitzgerald Overweight
2018-10-29 開始されました Citigroup Neutral
2018-08-17 ダウングレード Chardan Capital Markets Buy → Neutral
2017-10-06 再開されました Goldman Neutral
2017-09-13 繰り返されました Chardan Capital Markets Buy
2017-08-10 繰り返されました Chardan Capital Markets Buy
2017-01-24 アップグレード Robert W. Baird Neutral → Outperform
2016-05-18 開始されました BofA/Merrill Buy
2016-04-14 開始されました Robert W. Baird Neutral
2016-04-12 繰り返されました Chardan Capital Markets Buy
2015-09-16 ダウングレード Chardan Capital Markets Buy → Neutral
2015-06-16 繰り返されました Chardan Capital Markets Buy
すべてを表示

Amicus Therapeutics Inc (FOLD) 最新ニュース

pulisher
01:14 AM

How to Take Advantage of moves in (FOLD) - news.stocktradersdaily.com

01:14 AM
pulisher
Jun 01, 2025

Two Sigma Investments LP Boosts Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Jun 01, 2025
pulisher
May 31, 2025

Millennium Management LLC Has $4.31 Million Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 31, 2025
pulisher
May 31, 2025

Man Group plc Decreases Stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 31, 2025
pulisher
May 30, 2025

Amicus Therapeutics to Present at Upcoming Investor Conferences in June 2025 - GlobeNewswire

May 30, 2025
pulisher
May 30, 2025

Amicus Therapeutics to Present at Upcoming Investor Conferences in June 2025 | FOLD Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Rare Disease Leader Amicus Therapeutics to Present Latest Updates at Major Healthcare Conferences - Stock Titan

May 30, 2025
pulisher
May 30, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Sold by Voloridge Investment Management LLC - MarketBeat

May 30, 2025
pulisher
May 28, 2025

Squarepoint Ops LLC Purchases 753,060 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 28, 2025
pulisher
May 28, 2025

Neo Ivy Capital Management Increases Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 28, 2025
pulisher
May 28, 2025

Woodline Partners LP Sells 726,952 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 28, 2025
pulisher
May 27, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Purchased by Ameriprise Financial Inc. - Defense World

May 27, 2025
pulisher
May 26, 2025

Pompe Disease Market: Epidemiology, Therapies, Companies, - openPR.com

May 26, 2025
pulisher
May 26, 2025

Teza Capital Management LLC Sells 68,066 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 26, 2025
pulisher
May 26, 2025

Nuveen Asset Management LLC Purchases 159,139 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 26, 2025
pulisher
May 25, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

May 25, 2025
pulisher
May 25, 2025

297,830 Shares in Amicus Therapeutics, Inc. (NASDAQ:FOLD) Bought by Sovereign s Capital Management LLC - MarketBeat

May 25, 2025
pulisher
May 24, 2025

Vestal Point Capital LP Acquires New Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 24, 2025
pulisher
May 23, 2025

Deutsche Bank AG Grows Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 23, 2025
pulisher
May 21, 2025

Rafferty Asset Management LLC Sells 73,883 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 21, 2025
pulisher
May 21, 2025

Enzyme Replacement Therapy Market Set to Witness Significant - openPR.com

May 21, 2025
pulisher
May 20, 2025

Janus Henderson Group PLC Cuts Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 20, 2025
pulisher
May 20, 2025

Fabry Disease Market: Epidemiology, Therapies, Companies, - openPR.com

May 20, 2025
pulisher
May 20, 2025

Prosight Management LP Buys Shares of 920,000 Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 20, 2025
pulisher
May 20, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World

May 20, 2025
pulisher
May 19, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Acquired by D. E. Shaw & Co. Inc. - MarketBeat

May 19, 2025
pulisher
May 19, 2025

Enzyme Replacement Therapy Market Generated Opportunities, - openPR.com

May 19, 2025
pulisher
May 19, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Holdings Cut by BNP Paribas Financial Markets - MarketBeat

May 19, 2025
pulisher
May 18, 2025

Orbimed Advisors LLC Increases Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 18, 2025
pulisher
May 16, 2025

Northern Trust Corp Has $31.76 Million Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 16, 2025
pulisher
May 16, 2025

Hudson Bay Capital Management LP Buys 379,800 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 16, 2025
pulisher
May 16, 2025

Batten Disease Treatment Market Size, Outlook 2031 by Key - openPR.com

May 16, 2025
pulisher
May 16, 2025

Parkman Healthcare Partners LLC Has $7.39 Million Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 16, 2025
pulisher
May 15, 2025

Balyasny Asset Management L.P. Lowers Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 15, 2025
pulisher
May 14, 2025

Raymond James Financial Inc. Purchases Shares of 13,983 Amicus Therapeutics, Inc. (NASDAQ:FOLD) - Defense World

May 14, 2025
pulisher
May 13, 2025

Is Amicus Therapeutics (FOLD) the Best Low Priced Biotech Stock to Buy Now? - Insider Monkey

May 13, 2025
pulisher
May 12, 2025

Bayesian Capital Management LP Purchases 54,100 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 12, 2025
pulisher
May 12, 2025

10 Best Low-Priced Biotech Stocks to Buy Now - Insider Monkey

May 12, 2025

Amicus Therapeutics Inc (FOLD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Amicus Therapeutics Inc (FOLD) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Campbell Bradley L
President and CEO
Feb 19 '25
Sale
10.00
400
4,000
1,150,657
$1.0846
price down icon 1.76%
$29.97
price down icon 0.70%
$577.79
price up icon 0.89%
$306.27
price up icon 0.67%
$4.47
price down icon 2.22%
$489.50
price down icon 0.11%
大文字化:     |  ボリューム (24 時間):